EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Acute Effects of the 5‐Hydroxytryptamine Type 4 Receptor Agonist Mosapride on Pharyngeal Swallowing Physiology in Adults

Shu-Wei Liang iD, Jui-Sheng Hung, Taher Omari, Ming-Wun Wong, Wei-Yi Lei, Tso-Tsai Liu, Chih-Hsun Yi, Chien-Lin Chen iD

The Kaohsiung Journal of Medical Sciences · 2025

DOI: 10.1002/kjm2.70125 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2025. Verfasst von Shu-Wei Liang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Benzamides, Morpholines, Deglutition, Serotonin 5-HT4 Receptor Agonists. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 5‐hydroxytryptamine type 4 receptor agonist mosapride is known to modulate esophageal peristalsis and enhance lower esophageal sphincter compliance. However, its impact on oropharyngeal swallowing physiology remains insufficiently characterized. This study aimed to investigate the acute effects of mosapride on oropharyngeal swallowing dynamics in adults. Participants received either oral mosapride (40 mg) or placebo 1 h prior to testing in a randomized, crossover design. High‐resolution impedance manometry was performed using a solid‐state catheter to measure pressure and impedance within the oropharyngeal segment. Each participant underwent at least three swallows of 5, 10, and 20 mL thin and thick liquids administered by syringe. Manometric data were analyzed using the Swallow Gateway web‐based platform. Twenty‐four volunteers (13 male, mean age, 33 years; range, 24–56 years) completed the study. During thick swallows, mosapride significantly increased upper esophageal sphincter (UES) maximal opening admittance compared to placebo (5 mL: p = 0.017; 10 mL: p = 0.008) and reduced UES integrated relaxation pressure (10 mL: p = 0.018; 20 mL: p = 0.017). No significant effects were observed during thin liquid swallows. A marginal reduction in pre‐deglutitive UES basal pressure was noted during 5 mL thick swallows ( p = 0.050). Following adjustment using repeated measures ANOVA, only the reduction in UES basal pressure remained statistically significant ( p = 0.040). Acute administration of oral mosapride results in reduced UES basal tone in adults. These findings provide novel physiological evidence suggesting that mosapride may modulate neuroregulatory mechanisms controlling UES contractility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzamidesMorpholinesDeglutitionSerotonin 5-HT4 Receptor AgonistsPharynxReceptors, Serotonin, 5-HT4HumansMaleAdultFemaleMiddle AgedManometryYoung AdultCross-Over Studies

Stichwörter der Autor:innen

5‐hydroxytryptamine type 4 receptor agonisthigh‐resolution impedance manometrypharyngeal swallowing

Substanzen

mosaprideBenzamidesMorpholinesSerotonin 5-HT4 Receptor AgonistsReceptors, Serotonin, 5-HT4

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Department of Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan.
  • Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia.
  • Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan.

ORCID-Profile: Shu-Wei Liang, Chien-Lin Chen

Förderung

  • Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Zitieren

APA

Liang, S. W., Hung, J. S., Omari, T., Wong, M. W., Lei, W. Y., Liu, T. T., Yi, C. H., & Chen, C. L. (2025). Acute Effects of the 5‐Hydroxytryptamine Type 4 Receptor Agonist Mosapride on Pharyngeal Swallowing Physiology in Adults. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70125

Vancouver

Liang SW, Hung JS, Omari T, Wong MW, Lei WY, Liu TT, et al. Acute Effects of the 5‐Hydroxytryptamine Type 4 Receptor Agonist Mosapride on Pharyngeal Swallowing Physiology in Adults. The Kaohsiung Journal of Medical Sciences. 2025. doi:10.1002/kjm2.70125

BibTeX
@article{Liang2025,
  author = {Liang, Shu-Wei and Hung, Jui-Sheng and Omari, Taher and Wong, Ming-Wun and Lei, Wei-Yi and Liu, Tso-Tsai and Yi, Chih-Hsun and Chen, Chien-Lin},
  title = {Acute Effects of the 5‐Hydroxytryptamine Type 4 Receptor Agonist Mosapride on Pharyngeal Swallowing Physiology in Adults},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2025},
  doi = {10.1002/kjm2.70125}
}
Kostenlos starten →